Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion
Status: Recruiting
Location: See location...
Intervention Type: Device, Drug
Study Type: Observational
SUMMARY
This study mainly observed the ischemic index and vascular leakage index changes on ultra-wide field fluorescence angiography after anti-VEGF treatment , and whether these changes correlated with treatment efficacy in patients with macular edema secondary to retinal vein occlusion.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Male or female aged 18 years or older
• Macular edema secondary to CRVO,BRVO or HRVO
• Duration of RVO not more than 4 months
• Naïve patients. Patient with previous RVO (more than 12 months before the inclusion date) completely resolved (normalization of visual acuity and fundus examination) and who have experienced a recurrence of RVO are also considered naive
• Patient who agrees to participate in the study and who has given his/her written, informed consent
Locations
Other Locations
China
Renmin Hospital of Wuhan University
RECRUITING
Wuhan
Contact Information
Primary
CZ Chen, PHD
whuchenchzh@163.com
+86 13072765173
Time Frame
Start Date: 2023-10-09
Estimated Completion Date: 2025-12-15
Participants
Target number of participants: 60
Treatments
UWFA-RVO-ME
Ultra-wide-field fundus fluorescein angiography on patients with macular edema secondary to retinal vein occlusion treated with Ranibizumab
Related Therapeutic Areas
Sponsors
Leads: Renmin Hospital of Wuhan University